Theralase Technologies Inc. V.TLT

$TLTFF Feb1 till now Declining Volume Rising stock price.

[floatinketucky]

Bullish for sure. 

Consider the Five year price range and what was not a factor in that price. 

We never really knew if the FDA would grant a Phase 2 study. They did

We never really know if the FDA would grant a FTD. They did.

We never really knew if The FDA would consider BTD with 25 patients. They are. 

And the price of the stock is not reflecting any of this. 

Money is seeing this and the value at hand.

[99942Apophis]

floatinketucky wrote Bullish for sure.  Consider the Five year price range and what was not a factor in that price.  We never really knew if the FDA would grant a Phase 2 study. They did We never really know if the FDA would grant a FTD. They did. We never really knew if The FDA would consider BTD with 25 patients. They are.  And the price of the stock is not reflecting any of

[Rumpl3StiltSkin]

Yep, totally de-risked. IMO. We just need those CR %s to come in improved!

[floatinketucky]

It never to late to put out good information... Cheers!

[StevenBirch]

These are sluggish trading days for a lot of stocks but momentum is building.  When it was in teens you would see days where it was trying to go higher and it would trade at say 18 cents and immediately someone would offer some at 17 1/2 cents and it was done for the day. Now it's the opposite, today I checked and last sale was 28 cents and soon after someone bid 28 1/2 cents so it looks

[fredgoodwinson]

Well they`ll definitely have the 90-day results for both 13 and 14 by the end of this week. Whether they choose to release them immediately or with the Quarterly newsletter (which could be as far away as the end of April) remains to be seen.

[socalbob]

Hopefully the pullback in TLT this week isn't related to the 90-day results from patients 13/14.   It's been a very low volume week for this steep decline compared to the February run up in price.  Will need some solid efficacy results from the P2 study released to make the next move up to get past the wall of shares and warrants at $.30 / $.35

[fredgoodwinson]

Said as much in an earlier post Bob. The 90 day data for both will be there now. In the particular set of circumstances that TLT finds itself in it is exceptionally price-sensitive.Despite an affectation that information from a Clinical Trial is sacrosanct they`ve published results as early as 38 days after treatment when it suits them. Good or bad it should be released. 

[enriquesuave]

There is no wall of shares or warrants at 30/35  the shares have traded higher than 30 cents many times after financing and the warrants are trading on the venture exchange and will not be excercised until at least another 3.5 years from now or BO which ever comes first  IMO.  Coast is clear to move SP up to new levels, just need the data.  All IMO